Maria-Corina Serban Selected Research

Atorvastatin (Lipitor)

1/2017

Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria-Corina Serban Research Topics

Disease

7	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 04/2015
4	Myocardial Infarction 03/2020 - 01/2017
3	Coronary Disease (Coronary Heart Disease) 03/2020 - 01/2017
2	Muscular Diseases (Myopathy) 01/2020 - 01/2017
2	Diabetes Mellitus 01/2020 - 10/2016
2	Dyslipidemias (Dyslipidemia) 01/2020 - 09/2017
2	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2017
2	Rhabdomyolysis 03/2017 - 10/2016
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Atherosclerosis 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 04/2019
1	Abdominal Aortic Aneurysm 02/2017
1	Metabolic Diseases (Metabolic Disease) 01/2017
1	Hyperplasia 07/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2016
1	Thrombosis (Thrombus) 07/2016
1	Foreign Bodies (Foreign Body) 07/2016
1	Wasting Syndrome (Wasting Disease) 01/2016
1	Pulmonary Arterial Hypertension 01/2016
1	Chronic Renal Insufficiency 12/2015
1	Acute Disease 12/2015
1	Acidosis 12/2015
1	Anemia 12/2015
1	Inflammation (Inflammations) 04/2015
1	Insulin Resistance 01/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2015

Drug/Important Bio-Agent (IBA)

12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2020 - 01/2016
3	Ezetimibe (Zetia)FDA Link 01/2018 - 10/2016
3	Biomarkers (Surrogate Marker)IBA 02/2017 - 12/2016
3	Lipoprotein(a)IBA 02/2017 - 12/2016
2	AntioxidantsIBA 01/2020 - 12/2016
2	LipidsIBA 09/2017 - 04/2015
2	Hypolipidemic Agents (Antihyperlipidemics)IBA 03/2017 - 10/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2020
1	Angiotensin Receptor AntagonistsIBA 03/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	CurcuminIBA 01/2020
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 04/2019
1	oxidized low density lipoproteinIBA 04/2019
1	CholesterolIBA 04/2019
1	Phytosterols (Plant Sterols)IBA 01/2018
1	red yeast riceIBA 01/2018
1	BerberineIBA 01/2018
1	Tamoxifen FDA LinkGeneric 07/2017
1	Selective Estrogen Receptor Modulators (SERM)IBA 07/2017
1	Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA 02/2017
1	Proteins (Proteins, Gene)FDA Link 02/2017
1	HDL LipoproteinsIBA 02/2017
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2017
1	Atorvastatin (Lipitor)FDA Link 01/2017
1	3-hydroxyflavoneIBA 12/2016
1	QuercetinIBA 12/2016
1	AdiponectinIBA 10/2016
1	MetalsIBA 07/2016
1	MineralsIBA 12/2015
1	astaxanthine (astaxanthin)IBA 04/2015
1	Glucose (Dextrose)FDA LinkGeneric 04/2015
1	PolyphenolsIBA 01/2015
1	CarbohydratesIBA 01/2015

Therapy/Procedure

5	Therapeutics 04/2019 - 01/2016
1	Cardiac Rehabilitation 01/2017
1	Stents 07/2016